Company · Healthtech & Bio

Zymvol

zymvol.com ↗ ·Barcelona ·Seed

Zymvol Biomodeling is a Barcelona-based biotech company using physics-AI computational modeling to discover and engineer custom enzymes for pharmaceutical, chemical, and other industrial clients, cutting lab screening time. Founded in 2017 as a spinout from Barcelona Supercomputing Center researchers, it has completed 100+ projects for clients like Sanofi, Boehringer Ingelheim, and Axplora, and closed a €3M seed round in Feb 2025 led by Faber Ventures.

Founded

2017

Founders

News

Rounds

Investors

SectorsBiotechnology, Industrial Biotech, Synthetic Biology, Computational Chemistry, Green Chemistry Start-up MapHealthtech & Bio › R&D tools & software for life sciences

Profile updated 3 Aug 2026

Founders

Emanuele Monza

Co-Founder & former Chief Scientific Officer

Maria Fátima Lucas

Co-Founder & CEO

Víctor Gil

Co-Founder & former CTO

—

Global models

No comparables on record yet.

Investors 3

Elaia Partners

www.elaia.com ↗

Investor France

Faber Ventures

www.faber.vc ↗

Investor Portugal

Übermorgen Ventures

www.uebermorgen.vc ↗

Investor Switzerland

Funding rounds 2

Seed · €3M

ZYMVOL, a Barcelona Science Park biotech that uses computational modelling to discover and design industrial enzymes, raised a €3M seed roun…

2025-02-20

Seed · €1.3M

Zymvol raised a €1.3 million seed round led by French VC Elaia Partners to scale its computational discovery and design of industrial enzyme…

2023-02-27

News & media 4

Published	Article
2025-02-20	Barcelona's Zymvol secures €3M: CEO Maria Fátima Lucas on democratising enzyme development, market expansion, and more ↗ Silicon Canals
2025-02-20	ZYMVOL raises €3M for computational enzyme discovery and design ↗ Tech.eu
2024-01-17	Innovator Spotlight with Fátima Lucas ↗ Dealflow.EU
2023-11-14	Commission awards 2023 Innovation Radar award to Zymvol for developing ground-breaking software to design new enzymes ↗ European Commission - Shaping Europe's Digital Future